pUChTNFR55 vector (Cat. No.: V002379)

pUChTNFR554791 bp600120018002400300036004200M13 fwd5' UTR of human TNFR55TNFRSF1A3' UTR of human TNFR55MCSM13 revlac operatorlac promoterCAP binding siteoriAmpRAmpR promoter

Basic Information

Name:
pUChTNFR55
Antibiotic Resistance:
Ampicillin
Length:
4791 bp
Type:
Bacterial expression vector
Replication origin:
ori
Source/Author:
De Schamphelaire W, Olbrechts A, Meert J, Verhelst K, Roggeman Fonseca M, Vanhoucke M, Beyaert R.

pUChTNFR55 vector (Cat. No.: V002379) Annotation

LOCUS       V002379                 4791 bp    DNA     circular SYN 18-DEC-2018
DEFINITION  Exported.
ACCESSION   V002379
VERSION     V002379
KEYWORDS    .
SOURCE      synthetic DNA construct
  ORGANISM  synthetic DNA construct
            .
REFERENCE   1  (bases 1 to 4791)
  AUTHORS   De Schamphelaire W, Olbrechts A, Meert J, Verhelst K, Roggeman
            Fonseca M, Vanhoucke M, Beyaert R.
  TITLE     BCCM/LMBP Plasmid collection
  JOURNAL   Unpublished
REFERENCE   2  (bases 1 to 4791)
  AUTHORS   De Schamphelaire W.
  TITLE     Direct Submission
  JOURNAL   Submitted (02-FEB-2017) BCCM/LMBP, Universiteit Gent,
            Technologiepark 927, 9052, BELGIUM
REFERENCE   3  (bases 1 to 4791)
  TITLE     Direct Submission
REFERENCE   4  (bases 1 to 4791)
  AUTHORS   .
  TITLE     Direct Submission
COMMENT     SGRef: number: 1; type: "Journal Article"; journalName:
            "Unpublished"
            SGRef: number: 2; type: "Journal Article"; journalName: "Submitted
            (02-FEB-2017) BCCM/LMBP, Universiteit Gent, Technologiepark 927,
            9052, BELGIUM"
            SGRef: number: 3; type: "Journal Article"
FEATURES             Location/Qualifiers
     source          1..4791
                     /mol_type="other DNA"
                     /organism="synthetic DNA construct"
     primer_bind     379..395
                     /label="M13 fwd"
                     /note="common sequencing primer, one of multiple similar
                     variants"
     misc_feature    405..581
                     /label="5' UTR of human TNFR55"
                     /note="5' UTR of human TNFR55"
     CDS             582..1946
                     /gene="TNFRSF1A"
                     /label="Tumor necrosis factor receptor superfamily member
                     1A"
                     /note="Tumor necrosis factor receptor superfamily member 1A
                     from Homo sapiens. Accession#: P19438"
     misc_feature    1950..2490
                     /label="3' UTR of human TNFR55"
                     /note="3' UTR of human TNFR55"
     misc_feature    2501..2557
                     /label="MCS"
                     /note="pUC18/19 multiple cloning site"
     primer_bind     complement(2570..2586)
                     /label="M13 rev"
                     /note="common sequencing primer, one of multiple similar
                     variants"
     protein_bind    complement(2594..2610)
                     /label="lac operator"
                     /note="The lac repressor binds to the lac operator to
                     inhibit transcription in E. coli. This inhibition can be
                     relieved by adding lactose or
                     isopropyl-beta-D-thiogalactopyranoside (IPTG)."
     promoter        complement(2618..2648)
                     /label="lac promoter"
                     /note="promoter for the E. coli lac operon"
     protein_bind    complement(2663..2684)
                     /label="CAP binding site"
                     /note="CAP binding activates transcription in the presence
                     of cAMP."
     rep_origin      complement(2972..3560)
                     /direction=LEFT
                     /label="ori"
                     /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                     replication"
     CDS             complement(3734..4591)
                     /label="AmpR"
                     /note="beta-lactamase"
     promoter        complement(4592..4696)
                     /label="AmpR promoter"

This page is informational only.